About: covid:PMC7290210

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7290210 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Wang, Hui Zhao, Yong Wang, Yifei Zhang, Shuyang Xiao, Ying Zhang, Zhiyu Feng, Siqin Liu, Meixi Luan, Xiaodong Tian, Zhuang Wang, Yiyang Zhou, Ruilin
is schema:about of	named entity 'SARS-CoV-2' named entity 'receptor' named entity 'SARS-CoV' named entity 'eltrombopag' named entity 'hydrolyzed' named entity 'PBS' named entity 'ACE2' named entity 'aldosterone' named entity 'SARS-CoV-2' named entity 'ARB' named entity 'protein structure' named entity 'RBD' named entity 'binding affinity' named entity 'receptor' named entity 'coronavirus' named entity 'glycyrrhizic acid' named entity 'dissociation constant' named entity 'adverse effect' named entity 'homology modeling' named entity 'SPR' named entity 'hypertension' named entity 'protein synthesis' named entity 'infection' named entity 'ACEI' named entity 'ARB' named entity 'protein' named entity 'RBD' named entity 'protein tertiary structure' named entity 'small-molecule' named entity 'SPR' named entity 'eltrombopag' named entity 'SARS-CoV-2' named entity 'hepatitis B virus' named entity 'membrane fusion' named entity 'TSA' named entity 'Respiratory tract' named entity 'receptor agonist' named entity 'SARS-CoV-2' named entity 'Glycyrrhizic acid' named entity 'SARS-CoV-2' named entity 'Azilsartan medoxomil' named entity 'SARS-CoV-2' named entity 'ACE2' named entity 'drug design' named entity '7 nM' named entity 'viral proteins' named entity 'ARB' named entity 'Ewing sarcoma' named entity 'SPR' named entity 'host cells' named entity 'Dactinomycin' named entity 'biosensor' named entity 'spike protein' named entity 'SARS-CoV-2' named entity 'fever' named entity 'RNA' named entity 'epidemiological studies' named entity 'hydrogen bonds' named entity 'RBD' named entity 'dextran' named entity 'COVID' named entity 'coronavirus' named entity 'dimethylsulfoxide' named entity 'SARS-CoV-2' named entity 'CAMS' named entity 'spike protein' named entity 'eltrombopag' named entity 'HR2' named entity 'receptor' named entity 'viral proteins' named entity 'ACE2' named entity 'infection' named entity 'upregulated' named entity 'protein' named entity 'range of 0-1' named entity 'SARS-CoV-2' named entity 'ZnCl2' named entity 'glycyrrhizic acid' named entity 'ACE2' named entity '7 nM' named entity 'SARS-CoV2' named entity 'ACEI' named entity 'virus' named entity 'drug toxicity' named entity 'hypertension' named entity 'SPR' named entity 'anti-inflammatory effect' named entity 'ACE2'

Attributes

Values

Creator

Wang, Hui
Zhao, Yong
Wang, Yifei
Zhang, Shuyang
Xiao, Ying
Zhang, Zhiyu
Feng, Siqin
Liu, Meixi
Luan, Xiaodong
Tian, Zhuang
Wang, Yiyang
Zhou, Ruilin

is schema:about of

named entity 'SARS-CoV-2'
named entity 'receptor'
named entity 'SARS-CoV'
named entity 'eltrombopag'
named entity 'hydrolyzed'
named entity 'PBS'
named entity 'ACE2'
named entity 'aldosterone'
named entity 'SARS-CoV-2'
named entity 'ARB'
named entity 'protein structure'
named entity 'RBD'
named entity 'binding affinity'
named entity 'receptor'
named entity 'coronavirus'
named entity 'glycyrrhizic acid'
named entity 'dissociation constant'
named entity 'adverse effect'
named entity 'homology modeling'
named entity 'SPR'
named entity 'hypertension'
named entity 'protein synthesis'
named entity 'infection'
named entity 'ACEI'
named entity 'ARB'
named entity 'protein'
named entity 'RBD'
named entity 'protein tertiary structure'
named entity 'small-molecule'
named entity 'SPR'
named entity 'eltrombopag'
named entity 'SARS-CoV-2'
named entity 'hepatitis B virus'
named entity 'membrane fusion'
named entity 'TSA'
named entity 'Respiratory tract'
named entity 'receptor agonist'
named entity 'SARS-CoV-2'
named entity 'Glycyrrhizic acid'
named entity 'SARS-CoV-2'
named entity 'Azilsartan medoxomil'
named entity 'SARS-CoV-2'
named entity 'ACE2'
named entity 'drug design'
named entity '7 nM'
named entity 'viral proteins'
named entity 'ARB'
named entity 'Ewing sarcoma'
named entity 'SPR'
named entity 'host cells'
named entity 'Dactinomycin'
named entity 'biosensor'
named entity 'spike protein'
named entity 'SARS-CoV-2'
named entity 'fever'
named entity 'RNA'
named entity 'epidemiological studies'
named entity 'hydrogen bonds'
named entity 'RBD'
named entity 'dextran'
named entity 'COVID'
named entity 'coronavirus'
named entity 'dimethylsulfoxide'
named entity 'SARS-CoV-2'
named entity 'CAMS'
named entity 'spike protein'
named entity 'eltrombopag'
named entity 'HR2'
named entity 'receptor'
named entity 'viral proteins'
named entity 'ACE2'
named entity 'infection'
named entity 'upregulated'
named entity 'protein'
named entity 'range of 0-1'
named entity 'SARS-CoV-2'
named entity 'ZnCl2'
named entity 'glycyrrhizic acid'
named entity 'ACE2'
named entity '7 nM'
named entity 'SARS-CoV2'
named entity 'ACEI'
named entity 'virus'
named entity 'drug toxicity'
named entity 'hypertension'
named entity 'SPR'
named entity 'anti-inflammatory effect'
named entity 'ACE2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software